Dysregulation of the Wnt pathway inhibits timely myelination and remyelination in the mammalian CNS
Howard Hughes Medical Institute · California Institute for Regenerative Medicine · +5 more institutions
Abstract
The progressive loss of CNS myelin in patients with multiple sclerosis (MS) has been proposed to result from the combined effects of damage to oligodendrocytes and failure of remyelination. A common feature of demyelinated lesions is the presence of oligodendrocyte precursors (OLPs) blocked at a premyelinating stage. However, the mechanistic basis for inhibition of myelin repair is incompletely understood. To identify novel regulators of OLP differentiation, potentially dysregulated during repair, we performed a genome-wide screen of 1040 transcription factor-encoding genes expressed in remyelinating rodent lesions. We report that approximately 50 transcription factor-encoding genes show dynamic expression…
Citation impact
- FWCI
- —
- Percentile
- —
- References
- 48
Authors
9- SPStephen P.J. FancyCorresponding
Howard Hughes Medical Institute, California Institute for Regenerative Medicine, Wellcome/MRC Cambridge Stem Cell Institute, University of Cambridge
- SESergio E. Baranzini
University of California, San Francisco
- CZChao Zhao
Wellcome/MRC Cambridge Stem Cell Institute, University of Cambridge, MRC Centre for Regenerative Medicine
- DYDongin Yuk
Dana-Farber Cancer Institute
- KIKaren‐Amanda Irvine
University of California, San Francisco
Topics & keywords
- Remyelination
- Wnt signaling pathway
- Biology
- Oligodendrocyte
- TCF4
- Beta-catenin
- Myelin
- Cell biology